VEGFA and metabolic dysfunction-associated steatotic liver disease: In addition, liver tissues from patients with NAFLD with gallstones had increased levels of HIF-1α, HMOX1, and VEGFA mRNAs, compared with livers from patients with NAFLD without gallstones [46].